A step closer to effective transplant tolerance?

Nature Medicine

Volumn 18, Issue 5, 2012, Pages 664-665

  Waldmann, Herman ^a   Sykes, Megan ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988044963     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2770     Document Type: Article

References (11)

1. Leventhal, J. et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci. Transl. Med. 4, 124ra128 (2012).
2. Ildstad, S.T. & Sachs, D.H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307, 168–170 (1984).
3. Fudaba, Y. et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: In vivo and in vitro analyses. Am. J. Transplant. 6, 2121–2133 (2006).
4. Scandling, J.D. et al. Induced immune tolerance for kidney transplantation. N. Engl. J. Med. 365, 1359–1360 (2011).
5. Kawai, T. et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N. Engl. J. Med. 358, 353–361 (2008).
6. Newell, K.A. et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J. Clin. Invest. 120, 1836–1847 (2010).
7. Sagoo, P. et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J. Clin. Invest. 120, 1848–1861 (2010).
8. Vallera, D.A., Youle, R.J., Neville, D.M. Jr. & Kersey, J.H. Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti–Thy-1.2 coupled to the toxin ricin. J. Exp. Med. 155, 949–954 (1982).
9. Cobbold, S.P., Martin, G., Qin, S. & Waldmann, H. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 323, 164–166 (1986).
10. Bemelman, F., Honey, K., Adams, E., Cobbold, S. & Waldmann, H. Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. J. Immunol. 160, 2645–2648 (1998).
11. Brunstein, C.G. et al. Alternative donor transplantation after reduced intensity conditioning: Results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood 118, 282–288 (2011).